{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:26:39Z","timestamp":1783347999002,"version":"3.54.6"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K08CA293277"],"award-info":[{"award-number":["K08CA293277"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1245\/s10434-026-19667-1","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:40:15Z","timestamp":1776775215000},"page":"7483-7492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decision Modeling to Guide Management of Pancreatic IPMNs: Immediate Surgery or Initial Surveillance?"],"prefix":"10.1245","volume":"33","author":[{"given":"Greg D.","family":"Sacks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Marchegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"7","key":"19667_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00535-005-1646-4","volume":"40","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Kobayashi K, Mizumoto K, et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005;40(7):669\u201375.","journal-title":"J Gastroenterol"},{"issue":"2","key":"19667_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255\u201370.","journal-title":"Pancreatology"},{"issue":"4","key":"19667_CR3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.surg.2022.04.036","volume":"172","author":"F Aleotti","year":"2022","unstructured":"Aleotti F, Crippa S, Belfiori G, et al. Pancreatic resections for benign intraductal papillary mucinous neoplasms: collateral damages from friendly fire. Surgery. 2022;172(4):1202\u20139.","journal-title":"Surgery"},{"issue":"1","key":"19667_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","volume":"267","author":"MA Attiyeh","year":"2018","unstructured":"Attiyeh MA, Fern\u00e1ndez-Del Castillo C, Al Efishat M, et al. Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from The pancreatic surgery consortium. Ann Surg. 2018;267(1):157\u201363.","journal-title":"Ann Surg"},{"issue":"2","key":"19667_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/SLA.0000000000001569","volume":"264","author":"W Hogendoorn","year":"2016","unstructured":"Hogendoorn W, Moll FL, Sumpio BE, et al. Clinical decision analysis and markov modeling for surgeons: an introductory overview. Ann Surg. 2016;264(2):268\u201374.","journal-title":"Ann Surg"},{"issue":"3","key":"19667_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamasurg.2017.4587","volume":"153","author":"Y Hu","year":"2018","unstructured":"Hu Y, Johnston LE, Shami VM, et al. Comparative effectiveness of resection vs Surveillance for pancreatic branch duct intraductal papillary mucinous neoplasms with worrisome features. JAMA Surg. 2018;153(3):225\u201332.","journal-title":"JAMA Surg"},{"issue":"2","key":"19667_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.gastro.2009.10.001","volume":"138","author":"BM Weinberg","year":"2010","unstructured":"Weinberg BM, Spiegel BM, Tomlinson JS, et al. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138(2):531\u201340.","journal-title":"Gastroenterology"},{"issue":"1","key":"19667_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.hpb.2024.10.006","volume":"27","author":"GD Sacks","year":"2025","unstructured":"Sacks GD, Wojtalik L, Kaslow SR, et al. Identifying an optimal cancer risk threshold for resection of pancreatic intraductal papillary mucinous neoplasms. HPB (Oxford). 2025;27(1):94\u2013101.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"19667_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00595-019-01931-5","volume":"50","author":"S Hirono","year":"2020","unstructured":"Hirono S, Yamaue H. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas. Surg Today. 2020;50(1):50\u20135.","journal-title":"Surg Today"},{"issue":"4","key":"19667_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"FA Sonnenberg","year":"1993","unstructured":"Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322\u201338.","journal-title":"Med Decis Making"},{"issue":"6","key":"19667_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/SLA.0000000000001008","volume":"262","author":"G Marchegiani","year":"2015","unstructured":"Marchegiani G, Mino-Kenudson M, Ferrone CR, et al. Patterns of recurrence after resection of IPMN: Who, When, and How? Ann Surg. 2015;262(6):1108\u201314.","journal-title":"Ann Surg"},{"key":"19667_CR12","unstructured":"American College of Surgeons. ACS NSQIP Surgical Risk Calculator. ACS NSQIP Surgical Risk Calculator. https:\/\/riskcalculator.facs.org"},{"issue":"3","key":"19667_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s10620-009-1014-y","volume":"55","author":"ES Huang","year":"2010","unstructured":"Huang ES, Gazelle GS, Hur C. Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci. 2010;55(3):852\u201360.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"19667_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori KJ, Bratlie SO, Andersson B, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9(3):205\u201317.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"19667_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/SLA.0000000000004155","volume":"272","author":"SA Ahmad","year":"2020","unstructured":"Ahmad SA, Duong M, Sohal DPS, et al. Surgical outcome results from SWOG S1505: a randomized clinical trial of mFOLFIRINOX versus Gemcitabine\/Nab-paclitaxel for perioperative treatment of resectable pancreatic ductal adenocarcinoma. Ann Surg. 2020;272(3):481\u20136.","journal-title":"Ann Surg"},{"issue":"11","key":"19667_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, Dam JLv, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial. J Clin Oncol. 2022;40(11):1220\u201330.","journal-title":"J Clin Oncol"},{"issue":"7","key":"19667_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s11136-007-9226-0","volume":"16","author":"LS Matza","year":"2007","unstructured":"Matza LS, Boye KS, Yurgin N, et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res. 2007;16(7):1251\u201365.","journal-title":"Qual Life Res"},{"issue":"3","key":"19667_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10198-010-0224-8","volume":"12","author":"KS Boye","year":"2011","unstructured":"Boye KS, Matza LS, Walter KN, et al. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur J Health Econ. 2011;12(3):219\u201330.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"19667_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1056-8727(00)00061-1","volume":"14","author":"GC Brown","year":"2000","unstructured":"Brown GC, Brown MM, Sharma S, et al. Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complicat. 2000;14(1):18\u201324.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"19667_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcjd.2013.09.001","volume":"38","author":"S Harris","year":"2014","unstructured":"Harris S, Mamdani M, Galbo-J\u00f8rgensen CB, et al. The effect of hypoglycemia on health-related quality of life: Canadian results from a multinational time trade-off survey. Can J Diabetes. 2014;38(1):45\u201352.","journal-title":"Can J Diabetes"},{"issue":"11","key":"19667_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.hpb.2021.04.012","volume":"23","author":"AEJ Latenstein","year":"2021","unstructured":"Latenstein AEJ, Blonk L, Tjahjadi NS, et al. Long-term quality of life and exocrine and endocrine insufficiency after pancreatic surgery: a multicenter, cross-sectional study. HPB (Oxford). 2021;23(11):1722\u201331.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"19667_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.hpb.2017.03.007","volume":"19","author":"AU Blackham","year":"2017","unstructured":"Blackham AU, Doepker MP, Centeno BA, et al. Patterns of recurrence and long-term outcomes in patients who underwent pancreatectomy for intraductal papillary mucinous neoplasms with high grade dysplasia: implications for surveillance and future management guidelines. HPB (Oxford). 2017;19(7):603\u201310.","journal-title":"HPB (Oxford)"},{"issue":"11","key":"19667_CR23","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s11605-022-05428-4","volume":"26","author":"JR Habib","year":"2022","unstructured":"Habib JR, Kinny-K\u00f6ster B, Amini N, et al. Predictors, patterns, and timing of recurrence provide insight into the disease biology of invasive carcinomas arising in association with intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2022;26(11):2311\u201320.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"19667_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00535-019-01617-2","volume":"55","author":"S Hirono","year":"2020","unstructured":"Hirono S, Shimizu Y, Ohtsuka T, et al. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan pancreas society. J Gastroenterol. 2020;55(1):86\u201399.","journal-title":"J Gastroenterol"},{"issue":"4","key":"19667_CR25","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1097\/SLA.0000000000004478","volume":"276","author":"HS Kim","year":"2022","unstructured":"Kim HS, Han Y, Kang JS, et al. Fate of patients with intraductal papillary mucinous neoplasms of pancreas after resection according to the pathology and margin status: continuously increasing risk of recurrence even after curative resection suggesting necessity of lifetime surveillance. Ann Surg. 2022;276(4):e231\u20138.","journal-title":"Ann Surg"},{"issue":"2","key":"19667_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.hpb.2022.11.010","volume":"25","author":"K Johansen","year":"2023","unstructured":"Johansen K, Ghorbani P, Lundgren L, et al. Symptoms and life changes after total pancreatectomy: a qualitative study. HPB (Oxford). 2023;25(2):269\u201377.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"19667_CR27","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1245\/s10434-022-11326-5","volume":"29","author":"G Marchegiani","year":"2022","unstructured":"Marchegiani G, Crippa S, Perri G, et al. Surgery for intraductal papillary mucinous neoplasms of the pancreas: preoperative factors tipping the scale of decision-making. Ann Surg Oncol. 2022;29(5):3206\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"19667_CR28","doi-asserted-by":"publisher","first-page":"e1073","DOI":"10.1097\/SLA.0000000000005827","volume":"278","author":"GD Sacks","year":"2023","unstructured":"Sacks GD, Shin P, Braithwaite RS, et al. Risk perceptions and risk thresholds among surgeons in the management of intraductal papillary mucinous neoplasms. Ann Surg. 2023;278(5):e1073\u20139.","journal-title":"Ann Surg"},{"issue":"4157","key":"19667_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","volume":"185","author":"A Tversky","year":"1974","unstructured":"Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124\u201331.","journal-title":"Science"},{"issue":"1","key":"19667_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1037\/0033-295X.109.1.75","volume":"109","author":"DG Goldstein","year":"2002","unstructured":"Goldstein DG, Gigerenzer G. Models of ecological rationality: the recognition heuristic. Psychol Rev. 2002;109(1):75\u201390.","journal-title":"Psychol Rev"},{"issue":"5","key":"19667_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/00000658-199905000-00012","volume":"229","author":"KD Lillemoe","year":"1999","unstructured":"Lillemoe KD, Kaushal S, Cameron JL, et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg. 1999;229(5):693\u20138 (discussion 698-700).","journal-title":"Ann Surg"},{"issue":"2","key":"19667_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13651820510028936","volume":"7","author":"CK Ho","year":"2005","unstructured":"Ho CK, Kleeff J, Friess H, et al. Complications of pancreatic surgery. HPB (Oxford). 2005;7(2):99\u2013108.","journal-title":"HPB (Oxford)"},{"issue":"20","key":"19667_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","volume":"302","author":"SG Pauker","year":"1980","unstructured":"Pauker SG, Kassirer JP. The Threshold approach to clinical decision making. N Eng J Med. 1980;302(20):1109\u201317.","journal-title":"N Eng J Med"},{"issue":"4","key":"19667_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1053\/j.gastro.2015.02.035","volume":"148","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, Weinberg DS, Sch\u00fcnemann H, et al. Management of pancreatic cysts in an evidence-based world. Gastroenterology. 2015;148(4):692\u20135.","journal-title":"Gastroenterology"},{"issue":"10","key":"19667_CR35","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361\u20137.","journal-title":"J Gen Intern Med"},{"key":"19667_CR36","doi-asserted-by":"crossref","unstructured":"Canakis A, Maoz A, Tkacz JN et al. Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital. BMJ Open Gastroenterol 2020; 7 (1).","DOI":"10.1136\/bmjgast-2020-000430"},{"key":"19667_CR37","doi-asserted-by":"crossref","unstructured":"Hunink MGM, Weinstein MC, Wittenberg E et al. Decision making in health and medicine: integrating evidence and values, 2 edition: Cambridge University Press, Cambridge, 2014.","DOI":"10.1017\/CBO9781139506779"},{"issue":"10","key":"19667_CR38","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.14309\/ajg.0000000000000730","volume":"115","author":"JM Lobo","year":"2020","unstructured":"Lobo JM, Scheiman JM, Zaydfudim VM, et al. Clinical and economic outcomes of patients undergoing guideline-directed management of pancreatic cysts. Am J Gastroenterol. 2020;115(10):1689\u201397.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"19667_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.hpb.2015.10.010","volume":"18","author":"N Rezaee","year":"2016","unstructured":"Rezaee N, Barbon C, Zaki A, et al. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford). 2016;18(3):236\u201346.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"19667_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.surg.2023.02.006","volume":"174","author":"Y Vaalavuo","year":"2023","unstructured":"Vaalavuo Y, Vornanen M, Ahola R, et al. Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: a nationwide retrospective study. Surgery. 2023;174(1):75\u201382.","journal-title":"Surgery"},{"issue":"3","key":"19667_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41395-018-0403-2","volume":"114","author":"S Majumder","year":"2019","unstructured":"Majumder S, Philip NA, Singh Nagpal SJ, et al. High-grade dysplasia in resected main-duct intraductal papillary mucinous neoplasm (md-ipmn) is associated with an increased risk of subsequent pancreatic cancer. Am J Gastroenterol. 2019;114(3):524\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"19667_CR42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/SLA.0000000000003174","volume":"272","author":"M Del Chiaro","year":"2020","unstructured":"Del Chiaro M, Beckman R, Ateeb Z, et al. Main duct dilatation is the best predictor of high-grade dysplasia or invasion in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2020;272(6):1118\u201324.","journal-title":"Ann Surg"},{"issue":"5","key":"19667_CR43","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.pan.2020.06.011","volume":"20","author":"W Izumo","year":"2020","unstructured":"Izumo W, Higuchi R, Furukawa T, et al. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2020;20(5):895\u2013901.","journal-title":"Pancreatology"},{"issue":"6","key":"19667_CR44","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.pan.2017.08.073","volume":"17","author":"V Morales-Oyarvide","year":"2017","unstructured":"Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, et al. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma. Pancreatology. 2017;17(6):920\u20136.","journal-title":"Pancreatology"},{"issue":"2","key":"19667_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1245\/s10434-012-2702-y","volume":"20","author":"J LaFemina","year":"2013","unstructured":"LaFemina J, Katabi N, Klimstra D, et al. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20(2):440\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"19667_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cgh.2006.01.018","volume":"4","author":"P L\u00e9vy","year":"2006","unstructured":"L\u00e9vy P, Jouannaud V, O\u2019Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4(4):460\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"19667_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/SLA.0b013e3182a18f48","volume":"258","author":"K Sahora","year":"2013","unstructured":"Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? a critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258(3):466\u201375.","journal-title":"Ann Surg"},{"issue":"5","key":"19667_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2017.07.019","volume":"153","author":"I Pergolini","year":"2017","unstructured":"Pergolini I, Sahora K, Ferrone CR, et al. Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology. 2017;153(5):1284-1294.e1281.","journal-title":"Gastroenterology"},{"issue":"4","key":"19667_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/SLA.0000000000006383","volume":"280","author":"CJ Wehrle","year":"2024","unstructured":"Wehrle CJ, Hossain MS, Perlmutter B, et al. Consequences of a surveillance strategy for side-branch intraductal pancreatic mucinous neoplasms: long-term follow-up of one thousand cysts. Ann Surg. 2024;280(4):683\u201392.","journal-title":"Ann Surg"},{"issue":"3","key":"19667_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/gutjnl-2015-310162","volume":"66","author":"S Crippa","year":"2017","unstructured":"Crippa S, Bassi C, Salvia R, et al. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut. 2017;66(3):495.","journal-title":"Gut"},{"issue":"1","key":"19667_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12885-022-09650-w","volume":"22","author":"T Fuji","year":"2022","unstructured":"Fuji T, Umeda Y, Takagi K, et al. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection. BMC Cancer. 2022;22(1):588.","journal-title":"BMC Cancer"},{"issue":"2","key":"19667_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/SLA.0000000000000470","volume":"260","author":"MJ Kang","year":"2014","unstructured":"Kang MJ, Jang J-Y, Lee KB, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. 2014;260(2):356\u201363.","journal-title":"Ann Surg"},{"issue":"4","key":"19667_CR53","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jamcollsurg.2012.12.026","volume":"216","author":"J He","year":"2013","unstructured":"He J, Cameron JL, Ahuja N, et al. Is It necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216(4):657\u201365.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"19667_CR54","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1053\/gast.2002.36552","volume":"123","author":"ST Chari","year":"2002","unstructured":"Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123(5):1500\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"19667_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/SLA.0000000000006144","volume":"280","author":"J Lucocq","year":"2024","unstructured":"Lucocq J, Hawkyard J, Robertson FP, et al. Risk of recurrence after surgical resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia (ipmn) with patterns of distribution and treatment: an international, multicenter, observational study (ADENO-IPMN Study). Ann Surg. 2024;280(1):126\u201335.","journal-title":"Ann Surg"},{"issue":"52","key":"19667_CR56","doi-asserted-by":"publisher","first-page":"85776","DOI":"10.18632\/oncotarget.11769","volume":"7","author":"AN Hanania","year":"2016","unstructured":"Hanania AN, Bantis LE, Feng Z, et al. Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. 2016;7(52):85776\u201384.","journal-title":"Oncotarget"},{"issue":"1","key":"19667_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1148\/radiol.2015150217","volume":"279","author":"H-J Kang","year":"2016","unstructured":"Kang H-J, Lee JM, Joo I, et al. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas: comparison between multidetector CT and MR imaging with MR cholangiopancreatography. Radiology. 2016;279(1):128\u201339.","journal-title":"Radiology"},{"issue":"3","key":"19667_CR58","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1148\/radiol.2482071578","volume":"248","author":"H Ogawa","year":"2008","unstructured":"Ogawa H, Itoh S, Ikeda M, et al. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology. 2008;248(3):876\u201386.","journal-title":"Radiology"},{"issue":"1","key":"19667_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MPA.0b013e318181b90d","volume":"38","author":"S Nara","year":"2009","unstructured":"Nara S, Onaya H, Hiraoka N, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38(1):8\u201316.","journal-title":"Pancreas"},{"key":"19667_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2017.04.009","volume":"92","author":"J Toft","year":"2017","unstructured":"Toft J, Hadden WJ, Laurence JM, et al. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol. 2017;92:17\u201323.","journal-title":"Eur J Radiol"},{"issue":"2","key":"19667_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11605-011-1757-6","volume":"16","author":"CE Cauley","year":"2012","unstructured":"Cauley CE, Waters JA, Dumas RP, et al. Outcomes of primary surveillance for intraductal papillary mucinous neoplasm. J Gastrointest Surg. 2012;16(2):258\u201366.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"19667_CR62","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1245\/s10434-016-5661-x","volume":"24","author":"M Del Chiaro","year":"2017","unstructured":"Del Chiaro M, Ateeb Z, Hansson MR, et al. Survival analysis and risk for progression of intraductal papillary mucinous neoplasia of the pancreas (ipmn) under surveillance: a single-institution experience. Ann Surg Oncol. 2017;24(4):1120\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"19667_CR63","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379(25):2395\u2013406.","journal-title":"N Engl J Med"},{"key":"19667_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.18632\/oncotarget.12761","volume":"7","author":"J P\u00e9ron","year":"2016","unstructured":"P\u00e9ron J, Roy P, Conroy T, et al. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget. 2016;7:50.","journal-title":"Oncotarget"},{"issue":"11","key":"19667_CR65","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s11605-015-2885-1","volume":"19","author":"JN Leal","year":"2015","unstructured":"Leal JN, Kingham TP, D\u2019Angelica MI, et al. Intraductal papillary mucinous neoplasms and the risk of diabetes mellitus in patients undergoing resection versus observation. J Gastrointest Surg. 2015;19(11):1974\u201381.","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"19667_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MPA.0000000000002054","volume":"51","author":"SA Firkins","year":"2022","unstructured":"Firkins SA, Hart PA, Porter K, et al. Incidence and risk factors for new-onset diabetes mellitus after surgical resection of pancreatic cystic lesions: a marketscan study. Pancreas. 2022;51(5):427\u201334.","journal-title":"Pancreas"},{"key":"19667_CR67","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.hpb.2020.11.169","volume":"23","author":"J Underhill","year":"2021","unstructured":"Underhill J, Hyer JM, Aquina C, et al. A national analysis of the incidence and sequelae of pancreatogenic diabetes following pancreatic resection. HPB (Oxford). 2021;23:S71.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"19667_CR68","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ags3.12435","volume":"5","author":"D Yamada","year":"2021","unstructured":"Yamada D, Takahashi H, Asukai K, et al. Investigation of the influence of pancreatic surgery on new-onset and persistent diabetes mellitus. Ann Gastroenterol Surg. 2021;5(4):575\u201384.","journal-title":"Ann Gastroenterol Surg"},{"issue":"3","key":"19667_CR69","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.surg.2024.04.041","volume":"176","author":"T Kato","year":"2024","unstructured":"Kato T, Watanabe Y, Oshima Y, et al. Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: a retrospective study. Surgery. 2024;176(3):880\u20139.","journal-title":"Surgery"},{"issue":"2","key":"19667_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.hpb.2019.06.017","volume":"22","author":"A Hallac","year":"2020","unstructured":"Hallac A, Aleassa EM, Rogers M, et al. Exocrine pancreatic insufficiency in distal pancreatectomy: incidence and risk factors. HPB (Oxford). 2020;22(2):275\u201381.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"19667_CR71","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s11605-022-05302-3","volume":"26","author":"AS Thomas","year":"2022","unstructured":"Thomas AS, Huang Y, Kwon W, et al. Prevalence and risk factors for pancreatic insufficiency after partial pancreatectomy. J Gastrointest Surg. 2022;26(7):1425\u201335.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"19667_CR72","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s11605-018-04084-x","volume":"23","author":"J Kusakabe","year":"2019","unstructured":"Kusakabe J, Anderson B, Liu J, et al. Long-term endocrine and exocrine insufficiency after pancreatectomy. J Gastrointest Surg. 2019;23(8):1604\u201313.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"19667_CR73","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/SLA.0000000000002753","volume":"270","author":"G Gemenetzis","year":"2019","unstructured":"Gemenetzis G, Groot VP, Blair AB, et al. Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection. Ann Surg. 2019;270(2):340\u20137.","journal-title":"Ann Surg"},{"issue":"1","key":"19667_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12876-023-02739-x","volume":"23","author":"Z-M Wang","year":"2023","unstructured":"Wang Z-M, Ma H-B, Meng Y. Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis. BMC Gastroenterol. 2023;23(1):107.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"19667_CR75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","volume":"25","author":"F Huguet","year":"2007","unstructured":"Huguet F, Andr\u00e9 T, Hammel P, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR Phase II and III studies. J Clin Oncol. 2007;25(3):326\u201331.","journal-title":"J Clin Oncol"},{"key":"19667_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.681961","volume":"11","author":"X Huang","year":"2021","unstructured":"Huang X, You S, Ding G, et al. Sites of distant metastases and cancer-specific survival in intraductal papillary mucinous neoplasm with associated invasive carcinoma: a study of 1178 patients. Front Oncol. 2021;11:681961.","journal-title":"Front Oncol"},{"issue":"1","key":"19667_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13561-022-00413-8","volume":"12","author":"Y Takumoto","year":"2022","unstructured":"Takumoto Y, Sasahara Y, Narimatsu H, et al. Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan. Health Econ Rev. 2022;12(1):63.","journal-title":"Health Econ Rev"},{"key":"19667_CR78","doi-asserted-by":"publisher","first-page":"1275496","DOI":"10.3389\/frhs.2024.1275496","volume":"4","author":"Y Sasahara","year":"2024","unstructured":"Sasahara Y, Takumoto Y, Watanabe K, et al. Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians. Front Health Serv. 2024;4:1275496.","journal-title":"Front Health Serv"},{"key":"19667_CR79","doi-asserted-by":"publisher","first-page":"ii53","DOI":"10.1093\/annonc\/mdw199.173","volume":"27","author":"V Picozzi","year":"2016","unstructured":"Picozzi V, Narayanan S, Kayitalire L, et al. P-180 Health-related quality of life in patients with metastatic pancreatic cancer. Ann Oncol. 2016;27:ii53.","journal-title":"Ann Oncol"},{"issue":"4","key":"19667_CR80","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/cncr.26365","volume":"118","author":"JD Murphy","year":"2012","unstructured":"Murphy JD, Chang DT, Abelson J, et al. Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer. 2012;118(4):1119\u201329.","journal-title":"Cancer"},{"issue":"1","key":"19667_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40780-021-00210-1","volume":"7","author":"H Fujii","year":"2021","unstructured":"Fujii H, Koda M, Sadaka S, et al. Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study. J Pharm Health Care Sci. 2021;7(1):27.","journal-title":"J Pharm Health Care Sci"},{"issue":"2","key":"19667_CR82","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.3747\/co.20.1223","volume":"20","author":"VC Tam","year":"2013","unstructured":"Tam VC, Ko YJ, Mittmann N, et al. Cost-effectiveness of systemic therapies for metastatic pancreatic cancer. Curr Oncol. 2013;20(2):e90\u2013106.","journal-title":"Curr Oncol"},{"issue":"11","key":"19667_CR83","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1007\/s11999-014-3820-6","volume":"472","author":"Q Gu","year":"2014","unstructured":"Gu Q, Koenig L, Mather RC 3rd, et al. Surgery for hip fracture yields societal benefits that exceed the direct medical costs. Clin Orthop Relat Res. 2014;472(11):3536\u201346.","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"19667_CR84","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/10711007241262794","volume":"45","author":"PM Cirrincione","year":"2024","unstructured":"Cirrincione PM, Bram JT, Nichols ET, et al. Health state utilities and cost-effectiveness economic evaluation for treatment of a symptomatic accessory navicular. Foot Ankle Int. 2024;45(10):1156\u201367.","journal-title":"Foot Ankle Int"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19667-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:04:58Z","timestamp":1783346698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19667-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["19667"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19667-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}